Droncit

Deworming Pet Meds for Dogs & Cats

Droncit removes tapeworms from the intestinal tract. Separate tablets are available for cats and dogs, and an injectable form is also available for both species. Unlike many other wormers that contain multiple ingredients to treat several types of intestinal parasites, Droncit contains only one ingredient to treat only tapeworms. This prevents ingestion of unnecessary medications for fewer risks.

Benefits of Droncit:

• Eliminates tapeworm infections and associated symptoms
• Effective with a single dose
• Different tablets for cats and dogs for dosing convenience
• Easily administered scored oral tablets that can be given directly or crumbled and added to food
• Available as an intramuscular or subcutaneous injection as an alternative to oral administration
• Contains only one active ingredient
• No known contraindications

Droncit Canine is only for use in dogs. Droncit Feline is only for use in cats. Droncit Injectable is only for use in cats and dogs. Do not administer to other animals. Give this medication only to animals for which it was prescribed. Not for use in humans.

Read all instructions and precautionary statements from the manufacturer.

Use exactly as prescribed by your veterinarian.

Directions for Droncit Canine:

1. Do not fast your dog before or after administration.
2. Feed tablets directly by hand or crumble and add them to a small amount of food.
3. Give ½ tablet to dogs weighing less than 5 lbs.
4. Give 1 tablet to dogs weighing 6-10 lbs.
5. Give 1 ½ tablets to dogs weighing 11-15 lbs.
6. Give 2 tablets to dogs weighing 16-30 lbs.
7. Give 3 tablets to dogs weighing 31-45 lbs.
8. Give 4 tablets to dogs weighing 46-60 lbs.
9. Give 5 tablets to dogs weighing more than 60 lbs.
10. Do not exceed a 5-tablet dose.

Directions for Droncit Feline:

1. Do not fast your cat before or after administration.
2. Feed tablets directly by hand or crumble and add them to a small amount of food.
3. Give ½ tablet to cats weighing 4 lbs. or less.
4. Give 1 tablet to cats weighing 5-11 lbs.
5. Give 1 ½ tablets to cats weighing more than 11 lbs.
6. Do not exceed a 1 ½ tablet dose.

Directions for Droncit Injectable:

1. Inject Droncit intramuscularly or subcutaneously.
2. Sterilize the site of injection and the syringe.
3. Give 0.3 mL to dogs weighing 5 lbs. or less.
4. Give 0.5 mL to dogs weighing 6-10 lbs.
5. Give 1.0 mL to dogs weighing 11-25 lbs.
6. Give 0.2 mL per 5 lbs. of body weight to dogs weighing more than 25 lbs.
7. Do not exceed a 3.0 mL dose in dogs.
8. Give 0.2 mL to cats weighing less than 5 lbs.
9. Give 0.4 mL to cats weighing 5-10 lbs.
10. Give 0.6 mL to cats weighing more than 10 lbs.
11. Do not exceed a 0.6 mL dose in cats.

Frequency of Use:

Droncit requires a single dose to treat a tapeworm infection. Sometimes a second treatment is necessary. Your veterinarian may suggest a regular treatment schedule every 21 to 26 days for control of E. multilocularis tapeworms.

Storage:

Keep out of reach of children and animals.

Store Droncit tablets at room temperature, protected from moisture and heat. Store Droncit Injectable at room temperature, protected from heat.

It is a violation of Federal Law to use this product in a manner inconsistent with its labeling.

Praziquantel, the single active ingredient in Droncit, damages the tapeworm's skin in such a way that it cannot continue to resist digestion by its host. While tapeworms are usually fully digested, in some instances pieces may be seen in the stool. 

Droncit requires a prescription from your veterinarian.

Droncit (praziquantel)

Droncit Canine Active Ingredient (per tablet): praziquantel 34 mg

Droncit Feline Active Ingredient (per tablet): praziquantel 23 mg

Droncit Injectable Active Ingredient (per mL): praziquantel 56.8

Warnings:

Keep Droncit out of reach of children and animals. Do not use or store in or near open flame or heat.

Use Droncit Canine only in dogs. Use Droncit Feline only in cats. Use Droncit Injectable only in cats and dogs. Use only in the animal for which it was prescribed. Do not administer to other animals. Not for use in humans.

Follow the specifications of your veterinarian's prescription.

CAUTION: Droncit is not for dogs younger than 4 weeks of age or for cats younger than 6 weeks of age.

Do not exceed stated maximum doses.

Tapeworms may infect humans and other animals. Talk to your veterinarian about proper hygiene and preventive procedures.

Side effects may include vomiting, diarrhea, loss of appetite, or lethargy. Mention any observed adverse reactions to your veterinarian.

Some irritation may appear at the site of injection after administration of Droncit Injectable.

Sterilization of the site of injection and syringe helps prevent infections.

Droncit has been tested in breeding and pregnant cats and dogs. No adverse reactions were observed.

If you know of or suspect an overdose, contact your veterinarian right away.

Consult your veterinarian before concurrently administering other drugs or supplements. Do not give Droncit concomitantly with another tapeworm medication unless expressly instructed to do so by your veterinarian.

Elimination of fleas on your pet is important for preventing reinfection with tapeworms.

Warranty and Manufacturer Information:

Droncit is a Reg. TM of the parent company of Bayer AG, Leverkusen.

Bayer HealthCare LLC, Animal Health Division, Shawnee Mission, Kansas 66201 U.S.A.

Bayer, the Bayer Cross, and Droncit are trademarks of Bayer.

For customer service or to obtain product information, including Material Safety Data Sheet, call 1-800-633-3796. For medical emergencies or to report adverse reactions, call 1-800-422-9874.

Droncit Canine:

July, 2007

08957811, R.1

13512

NADA 111-798, Approved by FDA

Droncit Feline:

July, 2007

08954391, R.1

13509

NADA 111-798, Approved by FDA

Droncit Injectable:

December, 2003

08715559-79018310, R.13

NADA # 111-607, Approved by FDA